Riskpilot← Back to searchSign inGet full accessBlyme & Nielsen ApS
APSActiveCVR 20246235Moseranden 2Medical specialists activities · NACE 8622Est. 19971 employees
Revenue 2025
DKK 262K
-19% vs 2024
EBITDA margin
100.0%
+3% vs 2024
Equity ratio
52.6%
Financial strength
Net profit 2025
DKK 388K
+1146% vs 2024
| Revenue | DKK 262K | -19% |
| EBITDA | DKK 262K | +3% |
| Net profit | DKK 388K | +1146% |
| Total assets | DKK 5,4M | +0% |
| Equity | DKK 2,8M | +16% |
| Employees | 1 | — |
Legal name
Blyme & Nielsen ApS
CVR number
20246235
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
21. august 1997
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene.
Company purpose
Selskabets formål er at udøve rådgivning og konsulentvirksomhed samt ejerskab af
andre selskaber og dermed forbunden aktivitet.
Address
Moseranden 2
Phone
+4540107650
Email
steen@ingtrup.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 268 | 122 | 256 | 325 | 262 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -76 | 47 | 203 | 254 | 262 |
| Depreciation & amort. | -195 | -72 | -32 | -108 | -24 |
| EBIT | -272 | -25 | 171 | 146 | 238 |
| Net financials | 171 | -20 | -59 | 33 | 86 |
| Profit before tax | -101 | -45 | 112 | 179 | 391 |
| Tax | -0 | -0 | -206 | 216 | 3 |
| Net profit | -101 | -45 | 318 | -37 | 388 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2.820 | 2.220 | 5.748 | 5.416 | 5.409 |
| Equity | 2.223 | 2.178 | 2.496 | 2.459 | 2.847 |
| Long-term debt | 470 | 0 | 0 | 0 | 18 |
| Short-term debt | 126 | 42 | 3.252 | 2.957 | 2.544 |
| Total debt | 597 | 42 | 3.252 | 2.957 | 2.562 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20212025
Equity ratio
52.6%
This company
38.2%
Market median
+38% vs market
20212025
Return on equity
13.6%
This company
18.4%
Market median
+26% vs market
20212025
Net profit margin
148.1%
This company
8.1%
Market median
+1728% vs market
20212025
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20212025
Debt / equity
0.90×
This company
0.62×
Market median
+45% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via CVR / Virk · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
SI Audit | Audit | 1997 – 2019 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50–66.65% | 50–66.65% | 2017 | |
| Individual | 50–66.65% | 50–66.65% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Blyme & Nielsen ApS 
Nielsen Group 2015 ApSBoard members of Blyme & Nielsen ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Steen Ingtrup | Audit | 0 companies |